Search

Shares of Ligand Pharmaceuticals Incorporated (LGND) traded higher to a new 52-week high in today's trading. The stock is up 3.06% to EUR101.00 at the last check Tuesday. Ligand Pharmaceuticals [...]

JUPITER: LIGAND PHARMACEUTICALS INCORPORATED has issued the following news release: Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it has entered into a definitive agreement to acquire APEIRON Biologics AG, [...]

JUPITER: Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Verona Pharma plc has received approval from the U.S. Food and Drug Administration (FDA) for Ohtuvayretm (ensifentrine). Ohtuvayre is [...]

JUPITER: Ligand Pharmaceuticals Incorporated announced that its collaborator Merck, known as MSD outside the United States and Canada, has received approval from the U.S. Food and Drug Administration for CAPVAXIVEtm, [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated announced that effective March 1, 2024, Ligand's Human Capital Management and Compensation Committee approved the grant of a non-qualified stock option award to purchase 15,100 [...]

On Tuesday's pre-market session, 12 healthcare stocks experienced significant gains and losses. Janux Therapeutics (JANX) saw a 120.5% increase to $33.3, with a market value of $1.5 billion. Viking Therapeutics [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Eisai Co., Ltd. obtained marketing authorization approval in January 2024 from the Japanese Ministry of Health, Labour and [...]

SAN DIEGO: Ligand Pharmaceuticals Inc., announced that effective February 1, 2024, Ligand's Board of Directors approved the grant of non-qualified stock option awards to purchase an aggregate of 93,700 shares [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that the U.S. Food and Drug Administration (FDA) has approved ZELSUVMItm (berdazimer topical gel, 10.3%) for the treatment of molluscum contagiosum [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) hosted an Investor and Analyst Day in New York City earlier today. CEO Todd Davis and other members of Ligand's senior management team [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated will host its Investor and Analyst Day on Tuesday, December 12, 2023. Members of Ligand's senior management team will provide an update on the company's [...]

SAN DIEGO: Applied Biomedical Science Institute has issued the following news release: A collaborative scientific team led by researchers at the Applied Biomedical Science Institute (ABS), Scripps Research, Kansas State [...]

Washington, D.C: The New Civil Liberties Alliance has filed a petition for a writ of certiorari in Lemelson, et al. v. SEC, asking the U.S. Supreme Court to hear a [...]

DURHAM: Novan, Inc. has issued the following press release: Novan, Inc. (Nasdaq: NOVN) and its wholly owned subsidiary, EPI Health, LLC (collectively, 'the Company' or 'Novan'), today announced that it [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced that its partner Travere Therapeutics, Inc. (Nasdaq: TVTX) has received accelerated approval from the U.S. Food and Drug Administration (FDA) for FILSPARI [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated announced that its partner Novan, Inc., has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking marketing approval for [...]

Roth Capital has lifted Ligand Pharmaceuticals Incorporated LGND price target from $85 to $90. Roth Capital analyst Scott Henry maintained a Buy rating on the stock. Ligand Pharmaceuticals shares are [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated has issued the following news release: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announced the company has completed the expected tax-free spin-off of its OmniAb antibody discovery [...]

SAN DIEGO: Ligand Pharmaceuticals Incorporated has issued the following news release: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced the completion of its expected tax-free distribution (Distribution) of 100% of Ligand's [...]

SAN DIEGO: LIGAND PHARMACEUTICALS INCORPORATED has issued the following news release: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced the business combination (Business Combination) of Avista Public Acquisition Corp. II (APAC) [...]

EMERYVILLE: LIGAND PHARMACEUTICALS INCORPORATED has issued the following news release: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that on October 3, 2022, the Human Capital Management and Compensation Committee of [...]

EMERYVILLE: Ligand Pharmaceuticals Incorporated has issued the following news release: Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) today announced that its board of directors has set October 26, 2022 as the record [...]

This Week (March 21, 2022 to March 25, 2022) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $114.37 from the [...]

This Week (March 14, 2022 to March 18, 2022) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $111.94 from the [...]

This Week (March 7, 2022 to March 11, 2022) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $103.05 from the [...]

This Week (February 22, 2022 to February 25, 2022) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $101.05 from the [...]

This Week (February 14, 2022 to February 18, 2022) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $102.56 from the [...]

This Week (February 7, 2022 to February 11, 2022) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $120.55 from the [...]

This Week (January 31, 2022 to February 4, 2022) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $118.93 from the [...]

This Week (January 24, 2022 to January 28, 2022) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $116.75 from the [...]

This Week (January 18, 2022 to January 21, 2022) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $114.18 from the [...]

This Week (January 3, 2022 to January 7, 2022) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $144.63 from the [...]

This Week (December 27, 2021 to December 31, 2021) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $154.46 from the [...]

This Week (December 20, 2021 to December 23, 2021) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $161.18 from the [...]

This Week (December 13, 2021 to December 17, 2021) was profitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it went up to $146.03 from the [...]

This Week (December 6, 2021 to December 10, 2021) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $143.96 from the [...]

This Week (November 29, 2021 to December 3, 2021) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $150.72 from the [...]

This Week (November 22, 2021 to November 26, 2021) was unprofitable week for Ligand Pharmaceuticals Incorporated (LGND) at NASDAQ Stock Market, in which it lowered down to $156.85 from the [...]